SCHEMBL38655191

SCHEMBL38655191

COC(=O)C(C)(C)c1ccc(CO)nn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.37
PLCG1 P19174 1/20 0.35
CNR2 P34972 4/20 0.33
BRS3 P32247 1/20 0.33
CNR1 P21554 1/20 0.33
KCNN4 O15554 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
MEN1 O00255 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
DGAT1 O75907 1/20 0.30
SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38655652 0.86 CYP2C19 (0.36) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL31292084 0.82 PLCG1 (0.41) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL31292213 0.80 CYP2C19 (0.44) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL31292617 0.78 NNMT (0.44) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL38654859 0.78 CYP2C19 (0.40) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL31292083 0.78 CYP2C19 (0.40) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL31292247 0.77 LMNA (0.43) CYP2C19PLCG1CNR2CNR1KCNN4
SCHEMBL31292581 0.77 CYP2C19 (0.39) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL38654843 0.75 CYP2C19 (0.38) CYP2C19PLCG1CNR2BRS3CNR1
SCHEMBL31292092 0.74 CYP2C19 (0.40) CYP2C19PLCG1CNR2BRS3CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099466-A1 TARGETED PROTEIN DEGRADATION MONTE ROSA THERAPEUTICS AG (CH) 2026-05-15 WO disclosed